Mohrish Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.06 Cr
- Revenue Growth 11424.17%
- Profit Growth 12980.80%
- Ebitda 10465.09%
- Net Worth 13603.56%
- Total Assets 8939.23%
About Mohrish Pharmaceuticals
Mohrish Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 June 2015 (Nine years and eight months 3 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.06 Cr.
Rishabh Madan, Madhu Madan, Rakesh Madan, and One other member serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900DL2015PTC281795
- Company No.
281795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jun 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Mohrish Pharmaceuticals Private Limited offer?
Mohrish Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Psoriasis Ointment, Cosmetics, Hair & Beauty Products, Skin Care Cosmetics, Skin Gel, Anti Acne Drug, Ayurvedic,Herbal Products & Medicine, Ayurvedic Tablets, Body Cream, Mometasone Solution and Spray.
Who are the key members and board of directors at Mohrish Pharmaceuticals?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rakesh Madan ![]() | Director | 22-Jun-2015 | Current |
Rishabh Madan ![]() | Director | 30-Sep-2016 | Current |
Madhu Madan ![]() | Director | 30-Sep-2016 | Current |
Mohit Madan ![]() | Director | 22-Jun-2015 | Current |
Financial Performance of Mohrish Pharmaceuticals.
Mohrish Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11424.17% increase. The company also saw a substantial improvement in profitability, with a 12980.8% increase in profit. The company's net worth Soared by an impressive increase of 13603.56%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mohrish Pharmaceuticals?
Unlock access to Mohrish Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹20.63 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.18 Cr
- Others : 0.88 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Aug 2024 | Others | ₹4.00 M | Open |
28 Aug 2023 | Axis Bank Limited | ₹5.40 M | Open |
09 Aug 2022 | Others | ₹1.61 M | Open |
03 Aug 2022 | Others | ₹2.22 M | Open |
07 Feb 2022 | Axis Bank Limited | ₹6.40 M | Open |
How Many Employees Work at Mohrish Pharmaceuticals?
Mohrish Pharmaceuticals has a workforce of 48 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mohrish Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mohrish Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.